As of 2024-12-15, the Fair Value of Enzymatica AB (publ) (ENZY.ST) is -1.11 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.67 SEK, the upside of Enzymatica AB (publ) is -166.56%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -40.98 | -13.22 | -45.39 | -68.66 | -49.73 | -43.60 |
| YoY growth | 3.76% | 67.74% | -243.34% | -51.25% | 27.57% | -39.11% |
| Market Cap (mil) | 405.38 |
| P/E | |
| Forward P/E |
| EPS | -0.22 |
| Avg earnings growth rate | -39.11% |
| TTM earnings | -53.96 |